Home Medicine A neonate with mucolipidosis II and transient secondary hyperparathyroidism
Article
Licensed
Unlicensed Requires Authentication

A neonate with mucolipidosis II and transient secondary hyperparathyroidism

  • Carlos Leyva , Maria Buch , Klaas J. Wierenga , Gary Berkovitz and Tossaporn Seeherunvong EMAIL logo
Published/Copyright: November 23, 2019

Abstract

Background

Mucolipidosis II α/β (ML II) is an autosomal recessive disease associated with the abnormality of lysosomal enzyme trafficking.

Case presentation

We present an unusual patient with: (a) marked skeletal anomalies with secondary hyperparathyroidism; (b) serum intact parathyroid hormone level normalized by 7 weeks but abnormally elevated serum alkaline phosphate persisted; and (c) two mutations identified in the GNPTAB gene. One mutation, c.3503_3504delTC, is the most common mutation in ML II. However, the second mutation, c.2896delA, is a rare mutation for which clinical presentation has not been described previously.

Acknowledgments

None.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: There were no competing interests.

References

1. Velho RV, Harms FL, Danyukova T, Ludwig NF, Friez MJ, et al. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta and type III gamma: update on GNPTAB and GNPTG mutations. Hum Mutat 2019;40:842–64.10.1002/humu.23748Search in Google Scholar PubMed

2. Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 2004;12:87–92.10.1038/sj.ejhg.5201044Search in Google Scholar PubMed

3. Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105:151–6.10.1007/s004399900075Search in Google Scholar PubMed

4. Bao M, Booth JL, Elmendorf BJ, Canfield WM. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure. J Biol Chem 1996;271:31437–45.10.1074/jbc.271.49.31437Search in Google Scholar PubMed

5. Raas-Rothschild A, Cormier-Daire V, Bao M, Genin E, Salomon R, et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J Clin Invest 2000;105:673–81.10.1172/JCI5826Search in Google Scholar PubMed PubMed Central

6. Kudo M, Bao M, D’Souza A, Ying F, Pan H, et al. The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA. J Biol Chem 2005;280:36141–9.10.1074/jbc.M509008200Search in Google Scholar PubMed

7. National Center for Biotechnology Information. NM_024312.4 (GNPTAB):c.2896delA (p.Met966Cysfs). Updated Nov 25, 2018. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/96120/#clinical-assertions.Search in Google Scholar

8. Unger S, Paul DA, Nino MC, McKay CP, Miller S, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr 2005;164:236–43.10.1007/s00431-004-1591-xSearch in Google Scholar PubMed

9. Heo JS, Choi KY, Sohn SH, Kim C, Kim YJ, et al. A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth. Korean J Pediatr 2012;55:438–44.10.3345/kjp.2012.55.11.438Search in Google Scholar PubMed PubMed Central

Received: 2019-05-02
Accepted: 2019-07-05
Published Online: 2019-11-23
Published in Print: 2019-12-18

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Mini Review
  3. Can preimplantation genetic diagnosis be used for monogenic endocrine diseases?
  4. Original Articles
  5. The distribution of intrafamilial CYP21A2 mutant alleles and investigation of clinical features in Turkish children and their siblings in Southeastern Anatolia
  6. 3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary?
  7. Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway
  8. Once-weekly supervised combined training improves neurocognitive and psychobehavioral outcomes in young patients with type 1 diabetes mellitus
  9. Associations between thyroid-stimulating hormone, blood pressure and adiponectin are attenuated in children and adolescents with overweight or obesity
  10. Mental health of both child and parents plays a larger role in the health-related quality of life of obese and overweight children
  11. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs
  12. Effects of vitamin D and estrogen receptor polymorphisms on bone mineral density in adolescents with anorexia nervosa
  13. Case Reports
  14. Whole exome sequencing identified a heterozygous KCNJ2 missense variant underlying autosomal dominant familial hypokalemic periodic paralysis in a Pakistani family
  15. Infantile cerebral infarction caused by severe diabetic ketoacidosis in new-onset type 1 diabetes mellitus
  16. Gallstone formation due to rapid weight loss through hyperthyroidism
  17. A neonate with mucolipidosis II and transient secondary hyperparathyroidism
  18. Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0162/html
Scroll to top button